is president and managing partner of BioPlan Associates.
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.
A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
A CMO perspective on the CMO-client partnership.
The industry may not be ready for India and China as regulatory issues emerge.
Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial